BI-853520-IN-10018-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁
BI-853520-IN-10018-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁
BI-853520-IN-10018-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemEBI-853520Cat.No.:HY-122844CASNo.:1227948-82-4Synonyms:IN-10018分?式:C??H??F?N?O?分?量:588.55作?靶點(diǎn):FAK作?通路:ProteinTyrosineKinase/RTK儲(chǔ)存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性BI853520(IN-10018)?種具有?服活性的粘附斑激酶(FAK)強(qiáng)效抑制劑(重組FAKIC50=1nM),BI853520表現(xiàn)出對(duì)癌細(xì)胞的抗增殖活性。體外研究BI853520(0-3μM;2h)inhibitscancercellsgrowth[2].BI853520(0-30μM;4-6d)repressestumorcellproliferationandinvasiononlyin3Dculture[1].BI853520(0-10μM;24h)repressesY397-FAKautophosphorylation[1].BI853520(0.1μM;96h)showsafastandpotentinhibitionofFAKinthishighlymetastaticmurinebreastcancercellline[1].CellViabilityAssay[2]CellLine:PC-3cellsConcentration:0-3μMIncubationTime:2hoursResult:Resultedinaconcentration-dependentreductionofthesignalwithamedianEC50valueof1?nM.CellProliferationAssay[1]CellLine:4T1,Py2T,andPy2T-LTcells1/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemEConcentration:0-30μMIncubationTime:4-6daysResult:Indicatedthatthespecificinhibitionofcellproliferationandinvasionatlowdosesisfunctionalonlyinthree-dimensionalcellcultureconditions,whereascellsculturedonplasticonlyrespondtoBI853520atveryhigh,toxicdoses.WesternBlotAnalysis[1]CellLine:4T1,Py2T,andPy2T-LTcellsConcentration:0-10μMIncubationTime:24hoursResult:ReducedY397-FAKautophosphorylationinallcelltypes.WesternBlotAnalysis[1]CellLine:4T1,Py2T,andPy2T-LTcellsConcentration:0.1μMIncubationTime:96hoursResult:DecreasedY397-FAKautophosphorylationfollowing0.1?μMBI853520treatmentoccurredwithin10?minandwassubstantiallyreducedatleastforthefollowing48?h.體內(nèi)研究BI853520(oralgavage;50mg/kg;oncedaily;0-8weeks)treatmentsignificantlysuppressesprimarytumorgrowthofallthreecelllinesinvivo[1].AnimalModel:FVB/N,Balb/c,orimmunodeficientnude(nu/nu)micetransplantedwithPy2T,4T1,orMTflECadcells,respectively[1]Dosage:50mg/kgAdministration:Oralgavage;50mg/kg;oncedaily;0-8weeksResult:Decreasedtumorvolumesignificantlyovertime.REFERENCES[1].StefanieTiede,etal.TheFAKinhibitorBI853520exertsanti-tumoreffectsinbreastcancer.Oncogenesis.2018Sep20;7(9):73.[2].UlrichAHirt,etal.EfficacyofthehighlyselectivefocaladhesionkinaseinhibitorBI853520inadenocarcinomaxenograftmodelsislinkedtoamesenchymaltumorphenotype.Oncogenesis.2018Feb23;7(2):21.2/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemEMcePdfHeightCaution:Producthasnotbeenfullyvalidatedformedicalapplica

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論